Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Global diversity of the Ganoderma lucidum complex (Ganodermataceae, Polyporales) inferred from morphology and multilocus phylogeny.

Zhou LW, Cao Y, Wu SH, Vlasák J, Li DW, Li MJ, Dai YC.

Phytochemistry. 2015 Jun;114:7-15. doi: 10.1016/j.phytochem.2014.09.023. Epub 2014 Oct 25.

PMID:
25453909
2.

What is Antrodia sensu stricto?

Spirin V, Vlasák J, Niemelä T, Miettinen O.

Mycologia. 2013 Nov-Dec;105(6):1555-76. doi: 10.3852/13-039.

PMID:
24311543
3.

Norway spruce (Picea abies) genetic transformation with modified Cry3A gene of Bacillus thuringiensis.

Bříza J, Pavingerová D, Vlasák J, Niedermeierová H.

Acta Biochim Pol. 2013;60(3):395-400. Epub 2013 Jul 25.

4.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

5.

Fragmentation of monoclonal antibodies.

Vlasak J, Ionescu R.

MAbs. 2011 May-Jun;3(3):253-63. Epub 2011 May 1. Review.

6.

Isolation and characterization of IgG1 with asymmetrical Fc glycosylation.

Ha S, Ou Y, Vlasak J, Li Y, Wang S, Vo K, Du Y, Mach A, Fang Y, Zhang N.

Glycobiology. 2011 Aug;21(8):1087-96. doi: 10.1093/glycob/cwr047. Epub 2011 Apr 5.

7.

Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.

Wang W, Vlasak J, Li Y, Pristatsky P, Fang Y, Pittman T, Roman J, Wang Y, Prueksaritanont T, Ionescu R.

Mol Immunol. 2011 Mar;48(6-7):860-6. doi: 10.1016/j.molimm.2010.12.009. Epub 2011 Jan 21.

PMID:
21256596
8.

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.

Tielemans CL, Vlasak J, Kosa D, Billiouw JM, Verpooten GA, Mezei I, Ryba M, Peeters PC, Mat O, Jadoul MY, Polakovic V, Dhaene M, Treille S, Kuriyakose SO, Leyssen M, Houard SA, Surquin M.

Vaccine. 2011 Feb 1;29(6):1159-66. doi: 10.1016/j.vaccine.2010.12.009. Epub 2010 Dec 16.

PMID:
21167859
9.

Seroprevalence of hantavirus antibodies among chronic hemodialysis patients in the Czech Republic.

Pejcoch M, Pazdiora P, Eiselt J, Hájek V, Veselá E, Vlasák J, Benesová J, Kubátová A, Kríz B.

Epidemiol Mikrobiol Imunol. 2010 Feb;59(1):48-51.

PMID:
21105569
10.

Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions.

Wang S, Ionescu R, Peekhaus N, Leung JY, Ha S, Vlasak J.

J Chromatogr A. 2010 Oct 15;1217(42):6496-502. doi: 10.1016/j.chroma.2010.08.044. Epub 2010 Aug 21.

PMID:
20828701
11.

Kinetics of chemical degradation in monoclonal antibodies: relationship between rates at the molecular and peptide levels.

Ionescu R, Vlasak J.

Anal Chem. 2010 Apr 15;82(8):3198-206. doi: 10.1021/ac902752e.

PMID:
20302349
12.

Phosphomannose isomerase gene for selection in lettuce (Lactuca sativa L.) transformation.

Bríza J, Růzicková N, Niedermeierová H, Dusbábková J, Vlasák J.

Acta Biochim Pol. 2010;57(1):63-8. Epub 2010 Mar 16.

13.

Assessment and reduction of fluid overload using a body composition monitor.

Ponce P, Táborský P, Vlasák J.

NDT Plus. 2009 Aug;2(4):335-6. doi: 10.1093/ndtplus/sfp063. No abstract available.

PMID:
25984034
14.

Evidence for trisulfide bonds in a recombinant variant of a human IgG2 monoclonal antibody.

Pristatsky P, Cohen SL, Krantz D, Acevedo J, Ionescu R, Vlasak J.

Anal Chem. 2009 Aug 1;81(15):6148-55. doi: 10.1021/ac9006254.

PMID:
19591437
15.

Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody.

Sinha S, Zhang L, Duan S, Williams TD, Vlasak J, Ionescu R, Topp EM.

Protein Sci. 2009 Aug;18(8):1573-84. doi: 10.1002/pro.173.

16.

Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.

Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaïa N, Ionescu R, Beck A.

Anal Biochem. 2009 Sep 15;392(2):145-54. doi: 10.1016/j.ab.2009.05.043. Epub 2009 Jun 2.

PMID:
19497295
17.

Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors.

Bertolotti-Ciarlet A, Wang W, Lownes R, Pristatsky P, Fang Y, McKelvey T, Li Y, Li Y, Drummond J, Prueksaritanont T, Vlasak J.

Mol Immunol. 2009 May;46(8-9):1878-82. doi: 10.1016/j.molimm.2009.02.002. Epub 2009 Mar 6.

PMID:
19269032
18.

Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods.

Vlasak J, Ionescu R.

Curr Pharm Biotechnol. 2008 Dec;9(6):468-81. Review.

PMID:
19075686
19.

Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.

Smahel M, Poláková I, Pokorná D, Ludvíková V, Dusková M, Vlasák J.

Int J Oncol. 2008 Jul;33(1):93-101.

PMID:
18575754
20.

Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload.

Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Taborsky P, Tetta C, Velasco N, Vlasak J, Zaluska W, Wizemann V.

Nephrol Dial Transplant. 2008 Sep;23(9):2965-71. doi: 10.1093/ndt/gfn228. Epub 2008 May 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk